Physician profile
Jennifer Gerring
NPI 1528509957
$1,389.03
in general payments reported to CMS, 2019-2025
9 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $468 · 2022: $189 · 2023: $180 · 2024: $372 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $631.90 | 2021-2024 | Stravix, Iodosorb Ointment 40g USA, Acticoat 4" X 4" |
| Convatec INC. | $234.75 | 2021-2025 | |
| Hollister Incorporated | $165.78 | 2021-2025 | New Image, Adapt Ceraring |
| Bayer Healthcare Pharmaceuticals INC. | $125.01 | 2024 | |
| Leo Pharma INC. | $118.88 | 2024 | |
| Novo Nordisk INC | $48.66 | 2023 | |
| Integra Lifesciences Corporation | $27.68 | 2021 | |
| Hill-Rom Company, INC | $19.17 | 2021 | |
| Solventum Corporation | $17.20 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Gerring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.